Boer J - Search Results

1

Hidradenitis suppurativa: viewpoint on clinical phenotyping, pathogenesis and novel treatments.

van der Zee HH, Laman JD, Boer J, Prens EP. van der Zee HH, et al. Among authors: boer j. Exp Dermatol. 2012 Oct;21(10):735-9. doi: 10.1111/j.1600-0625.2012.01552.x. Epub 2012 Aug 7. Exp Dermatol. 2012. PMID: 22882284 Free article. Review.

2

The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa.

van der Zee HH, Boer J, Prens EP, Jemec GB. van der Zee HH, et al. Among authors: boer j. Dermatology. 2009;219(2):143-7. doi: 10.1159/000228337. Epub 2009 Jul 8. Dermatology. 2009. PMID: 19590174

3

Deroofing: a tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions.

van der Zee HH, Prens EP, Boer J. van der Zee HH, et al. Among authors: boer j. J Am Acad Dermatol. 2010 Sep;63(3):475-80. doi: 10.1016/j.jaad.2009.12.018. J Am Acad Dermatol. 2010. PMID: 20708472

4

Pathogenesis and pharmacotherapy of Hidradenitis suppurativa.

Nazary M, van der Zee HH, Prens EP, Folkerts G, Boer J. Nazary M, et al. Among authors: boer j. Eur J Pharmacol. 2011 Dec 15;672(1-3):1-8. doi: 10.1016/j.ejphar.2011.08.047. Epub 2011 Sep 14. Eur J Pharmacol. 2011. PMID: 21930119 Review.

5

Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity.

Schrader AM, Deckers IE, van der Zee HH, Boer J, Prens EP. Schrader AM, et al. Among authors: boer j. J Am Acad Dermatol. 2014 Sep;71(3):460-7. doi: 10.1016/j.jaad.2014.04.001. Epub 2014 May 28. J Am Acad Dermatol. 2014. PMID: 24880664

6

Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement.

Deckers IE, van der Zee HH, Boer J, Prens EP. Deckers IE, et al. Among authors: boer j. J Am Acad Dermatol. 2015 Mar;72(3):485-8. doi: 10.1016/j.jaad.2014.11.017. Epub 2015 Jan 10. J Am Acad Dermatol. 2015. PMID: 25582541

7

Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study.

Deckers IE, Janse IC, van der Zee HH, Nijsten T, Boer J, Horváth B, Prens EP. Deckers IE, et al. Among authors: boer j. J Am Acad Dermatol. 2016 Oct;75(4):755-759.e1. doi: 10.1016/j.jaad.2016.04.067. Epub 2016 Jul 21. J Am Acad Dermatol. 2016. PMID: 27453539

8

Hidradenitis suppurativa is not associated with the metabolic syndrome based on body type: A cross-sectional study.

Vossen ARJV, van der Zee HH, Onderdijk AJ, Boer J, Prens EP. Vossen ARJV, et al. Among authors: boer j. J Dermatol. 2017 Feb;44(2):154-159. doi: 10.1111/1346-8138.13572. Epub 2016 Sep 8. J Dermatol. 2017. PMID: 27608328

9

Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): A case series.

Riis PT, Boer J, Prens EP, Saunte DM, Deckers IE, Emtestam L, Sartorius K, Jemec GB. Riis PT, et al. Among authors: boer j. J Am Acad Dermatol. 2016 Dec;75(6):1151-1155. doi: 10.1016/j.jaad.2016.06.049. Epub 2016 Sep 28. J Am Acad Dermatol. 2016. PMID: 27692735

10

Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study.

Deckers IE, Benhadou F, Koldijk MJ, Del Marmol V, Horváth B, Boer J, van der Zee HH, Prens EP. Deckers IE, et al. Among authors: boer j. J Am Acad Dermatol. 2017 Jan;76(1):49-53. doi: 10.1016/j.jaad.2016.08.031. Epub 2016 Oct 25. J Am Acad Dermatol. 2017. PMID: 27793450

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,126 results

Search Page

Filters